Latest Mergers And Acquisitions News

Beacon Minerals has sold a significant portion of its Astral Resources shares, raising $5.9 million to support development at its Jaurdi Mill and Iguana projects.

Pure Foods Tasmania has completed a strongly oversubscribed $1.76 million capital raise and reported improved preliminary FY25 results, signaling progress in its turnaround strategy.

Uvre Limited is set to begin its inaugural diamond drilling program at the Waitekauri Gold Project in New Zealand, targeting historically high-grade gold zones near major deposits. The 3,000m program aims to unlock the resource potential of the Jubilee prospect and newly identified epithermal structures.

Prospech Limited has announced a pro-rata renounceable entitlement offer aiming to raise up to $1.62 million to fund metallurgical testing and exploration at its Korsnäs rare earth elements project in Finland. The offer is partially underwritten and includes attaching options, reflecting the company’s ongoing development efforts and funding needs.

RLF AgTech has completed a $4.5 million placement by issuing over 90 million new shares, bolstering its capacity to advance sustainable crop nutrition solutions across Australia and Asia.

Lion Selection Group has committed $1 million to Sunshine Metals, increasing its stake to 9.2% as Sunshine advances promising high-grade gold projects in North Queensland.

Prospech Limited has announced a 2-for-7 renounceable rights issue to raise up to $1.6 million, featuring attaching options exercisable at 4 cents. Directors are backing the raise, which will fund rare earth metallurgical work and exploration in Finland and Slovakia.

Lightning Minerals is set to commence a significant diamond drilling program targeting high-grade gold zones at its newly acquired Mt Turner project in Queensland, aiming to unlock deeper mineralisation along the Drummer Fault.

Lumos Diagnostics has secured a significant follow-on contract with Aptatek Biosciences to push forward the development of an innovative in-home monitoring device for Phenylketonuria (PKU), a rare genetic disorder. This next phase aims to bring the FDA Breakthrough Device-designated PheCheck™ closer to clinical trials and commercial readiness.

Clime Investment Management has reported a strong FY25 profit turnaround, posting $2.1 million pretax and amortisation profit and declaring a fully franked dividend. The company outlines ambitious growth and margin targets for FY26 amid strategic restructuring and technology investments.

Lumos Diagnostics, backed by BARDA, is set to begin a pivotal pediatric clinical study to extend the use of its rapid respiratory infection test, FebriDx, to children aged 2–12 in U.S. CLIA-waived settings, potentially unlocking a $1 billion market.

Horizon Gold has successfully completed its renounceable entitlement issue, raising nearly $7 million including a full shortfall placement, positioning the company for further development at its Gum Creek Gold Project.